JP2008508307A5 - - Google Patents

Download PDF

Info

Publication number
JP2008508307A5
JP2008508307A5 JP2007523826A JP2007523826A JP2008508307A5 JP 2008508307 A5 JP2008508307 A5 JP 2008508307A5 JP 2007523826 A JP2007523826 A JP 2007523826A JP 2007523826 A JP2007523826 A JP 2007523826A JP 2008508307 A5 JP2008508307 A5 JP 2008508307A5
Authority
JP
Japan
Prior art keywords
dipyridin
ylethyl
pyridin
benzonitrile
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007523826A
Other languages
English (en)
Japanese (ja)
Other versions
JP4719745B2 (ja
JP2008508307A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/026868 external-priority patent/WO2006015159A2/en
Publication of JP2008508307A publication Critical patent/JP2008508307A/ja
Publication of JP2008508307A5 publication Critical patent/JP2008508307A5/ja
Application granted granted Critical
Publication of JP4719745B2 publication Critical patent/JP4719745B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007523826A 2004-07-29 2005-07-27 カリウムチャンネル阻害剤 Expired - Fee Related JP4719745B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59217704P 2004-07-29 2004-07-29
US60/592,177 2004-07-29
PCT/US2005/026868 WO2006015159A2 (en) 2004-07-29 2005-07-27 Potassium channel inhibitors

Publications (3)

Publication Number Publication Date
JP2008508307A JP2008508307A (ja) 2008-03-21
JP2008508307A5 true JP2008508307A5 (enExample) 2011-03-17
JP4719745B2 JP4719745B2 (ja) 2011-07-06

Family

ID=35787837

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007523826A Expired - Fee Related JP4719745B2 (ja) 2004-07-29 2005-07-27 カリウムチャンネル阻害剤

Country Status (7)

Country Link
US (1) US7879839B2 (enExample)
EP (1) EP1781635B1 (enExample)
JP (1) JP4719745B2 (enExample)
CN (1) CN1993347A (enExample)
AU (1) AU2005267884B2 (enExample)
CA (1) CA2575003C (enExample)
WO (1) WO2006015159A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006306542B2 (en) * 2005-10-21 2012-04-19 Merck Sharp & Dohme Corp. Potassium channel inhibitors
EP1951672B1 (en) * 2005-10-21 2011-05-25 Merck Sharp & Dohme Corp. Potassium channel inhibitors
WO2007089743A2 (en) * 2006-02-01 2007-08-09 Merck & Co., Inc. Potassium channel inhibitors
WO2007089735A2 (en) * 2006-02-01 2007-08-09 Merck & Co., Inc. Potassium channel inhibitors
EP1994029B1 (en) * 2006-02-01 2011-10-05 Merck Sharp & Dohme Corp. Potassium channel inhibitors
CN102216276A (zh) 2008-09-11 2011-10-12 辉瑞大药厂 取代的杂芳基物
EP2389374A1 (en) 2009-01-20 2011-11-30 Pfizer Inc. Substituted pyrazinone amides
JP5086480B2 (ja) 2009-03-11 2012-11-28 ファイザー・インク グルコキナーゼ活性化剤として使用されるベンゾフラニル誘導体
WO2012082746A2 (en) 2010-12-13 2012-06-21 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
FR2969606B1 (fr) * 2010-12-22 2013-01-11 Pf Medicament Derives de diarylpyridazinones, leur preparation et leur application en therapeutique humaine
SG11201406552UA (en) 2012-04-25 2014-11-27 Takeda Pharmaceutical Nitrogenated heterocyclic compound
US9527841B2 (en) 2012-07-13 2016-12-27 Takeda Pharmaceutical Company Limited Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors
SG11201500585XA (en) 2012-10-29 2015-04-29 Hoffmann La Roche 3,4-disubstituted oxazolidinone derivatives and their use as inhibitors of the calcium activated potassium channel
US9573961B2 (en) 2012-12-19 2017-02-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2014126944A2 (en) 2013-02-18 2014-08-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
JP6280912B2 (ja) 2013-03-14 2018-02-14 武田薬品工業株式会社 複素環化合物
US9765074B2 (en) 2013-03-15 2017-09-19 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
CN105121411B (zh) 2013-04-15 2017-10-10 杜邦公司 杀真菌酰胺
WO2015002231A1 (ja) 2013-07-03 2015-01-08 武田薬品工業株式会社 複素環化合物
EP3018123B1 (en) 2013-07-03 2023-05-10 Takeda Pharmaceutical Company Limited Amide compound
WO2015012328A1 (ja) 2013-07-24 2015-01-29 武田薬品工業株式会社 複素環化合物
US9751881B2 (en) 2013-07-31 2017-09-05 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
SI3050878T1 (sl) 2013-09-24 2022-01-31 Fujifilm Corporation Nova dušik-vsebujoča spojina ali njena sol ali kovinski kompleks le-te
EP3061754A4 (en) 2013-10-23 2017-03-22 Takeda Pharmaceutical Company Limited Heterocyclic compound
EP3063142B1 (en) 2013-10-31 2019-01-30 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2016127358A1 (en) 2015-02-12 2016-08-18 Merck Sharp & Dohme Corp. Inhibitors of renal outer medullary potassium channel
CN104926716A (zh) * 2015-06-10 2015-09-23 哈尔滨工业大学 吡啶衍生物2,6-二[(6-甲氧基吡啶-2-基)甲基]吡啶及其合成方法
CN104844503A (zh) * 2015-06-10 2015-08-19 哈尔滨工业大学 吡啶衍生物6-[(6-甲氧基吡啶-2-基)甲基]-2,2’-吡啶及其合成方法
US11166940B2 (en) * 2016-12-22 2021-11-09 Ramot At Tel-Aviv University Ltd. Treatment of cardiac disorders by blocking SK4 potassium channel
JP2021523092A (ja) * 2018-03-21 2021-09-02 ピラマル・ファーマ・リミテッドPiramal Pharma Limited アルファ−(ジアリールメチル)アルキルアミンの改良された不斉合成
SMT202400003T1 (it) * 2019-02-06 2024-03-13 Lilly Co Eli Derivati di 1-((2-(2,2,2-trifluoroetossi)piridin-4-il)metil)urea come potenziatori di kcnq
WO2024223617A1 (en) * 2023-04-24 2024-10-31 Fundamental Pharma Gmbh Effective means to modulate nmda receptor-mediated toxicity

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB765853A (en) 1952-04-03 1957-01-16 Abbott Lab Improvements in or relating to substituted piperidines
GB915804A (en) * 1958-04-12 1963-01-16 Degussa Process for the production of basically substituted carboxylic acid amides
EP0435127A3 (en) * 1989-12-29 1991-12-27 Basf Aktiengesellschaft 3-substituted pyridines
US6632836B1 (en) 1998-10-30 2003-10-14 Merck & Co., Inc. Carbocyclic potassium channel inhibitors
DE60132606T2 (de) 2000-09-20 2009-02-19 Merck & Co., Inc. Isochinolinone als kalium-kanal-inhibitoren
AU2003201273A1 (en) * 2002-01-04 2003-07-30 Poseidon Pharmaceuticals A/S Potassium channel modulators
JP4719681B2 (ja) 2003-09-23 2011-07-06 メルク・シャープ・エンド・ドーム・コーポレイション キナゾリンカリウムチャネル阻害剤
AU2004276268B2 (en) 2003-09-23 2009-01-29 Merck Sharp & Dohme Corp. Isoquinoline potassium channel inhibitors
CA2539479C (en) 2003-09-23 2010-07-06 Merck & Co., Inc. Isoquinoline potassium channel inhibitors
US7692017B2 (en) 2003-09-23 2010-04-06 Merck Sharp & Dohme Corp. Quinoline potassium channel inhibitors
WO2005030791A2 (en) 2003-09-23 2005-04-07 Merck & Co., Inc. Isoquinolinone potassium channel inhibitors
CA2539541C (en) 2003-09-23 2010-06-29 Merck & Co., Inc. Isoquinolinone potassium channel inhibitors
CA2539729C (en) 2003-09-23 2010-09-07 Merck & Co., Inc. Isoquinolinone potassium channel inhibitors
CN1856470A (zh) 2003-09-23 2006-11-01 默克公司 喹啉钾通道抑制剂
DE102005028845A1 (de) * 2005-06-22 2006-12-28 Sanofi-Aventis Deutschland Gmbh Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen

Similar Documents

Publication Publication Date Title
JP2008508307A5 (enExample)
CA2575003A1 (en) Potassium channel inhibitors
RU2396269C2 (ru) Производные гетероарилзамещенного пиперидина в качестве ингибиторов печеночной карнитин пальмитоилтрансферазы (l-cpt1)
RU2016133684A (ru) Бициклические азот-содержащие соединения как агонисты М1 мускариновых рецепторов
JP2005500986A5 (enExample)
JP2007508346A5 (enExample)
HRP20241201T1 (hr) Novi heterociklički spojevi kao inhibitori monoacilglicerol lipaze
JP2019530667A5 (enExample)
USRE49700E1 (en) Substituted nitrogen containing compounds
CA2440238A1 (en) Novel amines as histamine-3 receptor ligands and their therapeutic applications
RU2017124425A (ru) Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg
IL306126A (en) Heterocyclic compounds
RU2010137300A (ru) Модуляторы бета-амилоида
JP2014510708A5 (enExample)
JP2014517833A5 (enExample)
SI3177619T1 (en) 2- (morpholin-4-yl) -1,7-naphthyridines
FI3768684T3 (fi) Oksatsiinimonoasyyliglyserolilipaasin (magl) estäjiä
RU2007101612A (ru) N-(бензил-4-фенил-1н-имидазол-2-ил)-2, 2-диметилпропил)бензамидные производные и родственные соединения в качестве ингибиторов кинезинового белка веретена (ksp) для лечения рака
AR064302A1 (es) Arilpirazoles sustitudos
CO6660490A2 (es) Composiciones solidas
RU2006127572A (ru) Полигетероциклические соединения и их применение в качестве антагонистов метаботропного рецептора глутамата
JPWO2021087025A5 (enExample)
JP2017502049A5 (enExample)
JPWO2020231808A5 (enExample)
JP2016536333A5 (enExample)